These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 17172902)
1. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia. Huerva V; Mateo AJ; Mangues I; Jurjo C Cornea; 2006 Dec; 25(10):1220-3. PubMed ID: 17172902 [TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Boehm MD; Huang AJ Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333 [TBL] [Abstract][Full Text] [Related]
3. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Di Pascuale MA; Espana EM; Tseng SC Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965 [TBL] [Abstract][Full Text] [Related]
4. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Vann RR; Karp CL Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787 [TBL] [Abstract][Full Text] [Related]
5. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Dudney BW; Malecha MA Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170 [TBL] [Abstract][Full Text] [Related]
6. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Krilis M; Tsang H; Coroneo M Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834 [TBL] [Abstract][Full Text] [Related]
7. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Zaki AA; Farid SF Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Schechter BA; Koreishi AF; Karp CL; Feuer W Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C. Tseng SH; Tsai YY; Chen FK Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223 [TBL] [Abstract][Full Text] [Related]
12. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Shields CL; Naseripour M; Shields JA Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855 [TBL] [Abstract][Full Text] [Related]
13. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C. Haas K; Ben-Dor D; Levartovsky S Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591 [No Abstract] [Full Text] [Related]
14. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy. Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105 [TBL] [Abstract][Full Text] [Related]
16. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia. Huerva V; Sánchez MC; Mangues I J Ocul Pharmacol Ther; 2007 Apr; 23(2):143-5. PubMed ID: 17444802 [TBL] [Abstract][Full Text] [Related]
17. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803 [TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594 [TBL] [Abstract][Full Text] [Related]
19. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Karp CL; Moore JK; Rosa RH Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635 [TBL] [Abstract][Full Text] [Related]
20. Topical medical therapies for ocular surface tumors. Poothullil AM; Colby KA Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]